• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Oncology
    • Cell Therapy at the Limits 2020
    • UCL Frontiers of Oncology 2019
      • Haematology
      • Melanoma
      • Urology
      • Women’s Health
      • Lung Cancer
      • Gastrointestinal Oncology
      • Paediatric Oncology
      • Supporters
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
        • Introduction
        • Programme
        • Chairs
        • Venue
        • Sponsor Packages
        • Supporters
      • Oncology at the Limits 2017
        • Introduction
        • Chairs
        • Programme
        • Schedule
        • Venue
        • Hotel
        • Information
        • Supporters
        • OATL 2017: Login
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Previous Events
      • Multiple Sclerosis Nurses at the Limits 2019
        • Introduction
        • Express Interest in MSNATL 2020
        • Programme
        • Chairs
        • Venue
        • Hotel
        • Information
        • Conflict of Interest Forms
        • Supporters
      • MSATL 2018: Introduction
        • MSATL 2018: Programme
        • MSATL 2018: Chairs
        • MSATL 2018: Schedule
        • MSATL 2018: Venue
        • MSATL 2018: Hotel
        • MSATL 2018: Information
        • MSATL 2018: CME Accreditation
        • MSATL 2018: Supporters
        • MSATL 2018: Conflict of Interest Forms
      • MSATL 2017: Introduction
        • MSATL 2017: Chairs
        • MSATL 2017: Schedule
        • MSATL 2017: Programme
        • MSATL 2017: Venue
        • MSATL 2017: Supporters
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Register Interest
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series 2018
    • Multiple Sclerosis at the Limits 2018
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Hatter Horizon Series 2017
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017
  • Supporters

Professor Irving Weissman

Irving Weissman received his B.S. from Montana State University in 1960 and an MD from Stanford University in 1965.  During medical school he did research on thymus cell migration with James Gowans in 1964 at Oxford University, England.  He was a postdoctoral fellow in Dr. H. S. Kaplan’s laboratory at Stanford University from 1965-1967, and was appointed as a Research Associate in the Department of Radiology upon completion of the fellowship.  He was appointed Assistant Professor of Pathology, Stanford School of Medicine in 1969, Associate Professor in 1974, and Professor in 1990.  He was an Investigator of the Howard Hughes Medical Institute from 1990-1992.

He was the Karel Beekhuis Professor of Cancer Biology from 1987 until 2005 and the Chair of the Immunology Program, a degree-granting program from 1986-2001. In 2002 he became Director of the Stanford Cancer/Stem Cell Institute, which was split into the Stanford Institute of Stem Cell Biology and Regenerative Medicine, and the Stanford Cancer Center in 2003; Weissman was Director of both, and was PI on the successful NCI Cancer Center grant. He stepped down as Cancer Center Director in 2008, but remains director of the Stem Cell Institute. In May 2005, he was named the Virginia and D. K. Ludwig Professor for Clinical Investigation in Cancer Research.

« Professor David L Porter
Dr Scott W Lowe »

Hatter Horizon GP Meeting
Tuesday, 3 December 2019
London, UK

Hatter Horizon Series
Monday, 9 December 2019
London, UK

Multiple Sclerosis Nurses at the Limits
Friday, 10 & Saturday, 11 January 2020, London, UK

Multiple Sclerosis at the Limits
Thursday, 23 & Friday, 24 January 2020, London, UK

Frontiers of Oncology: Colorectal Cancer
February 2020, London, UK

Cardiology, Diabetes & Nephrology at the Limits 2020
Monday, 20 - Wednesday, 22 April 2020, London, UK

Cell Therapy at the Limits 2020
Monday, 16 - Tuesday, 17 November 2020, London, UK

The 18th Malvern Diabetic Foot Conference
Wednesday, 13 - Friday, 15 May 2020, Malvern, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 17 - Saturday, 18 July 2020, São Paulo, Brazil

Cardiology, Diabetes & Nephrology at the Limits Canada
Monday, 4 - Tuesday, 5 May 2020, Toronto, Canada

  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2019 At the Limits Ltd.
This site uses cookies More info